Web15 feb. 2024 · Nureca Limited IPO GMP – Check Latest IPO Grey Market Premium. Last Updated Date: Nov 17, 2024. Nureca Limited is about to release its IPO on Feb 15, 2024. The issue is closing on Feb 17, 2024 and is currently having an active grey market. The Nureca Limited IPO GMP is running at a stable rate as per the current situation. Web14 feb. 2024 · NURECA IPO REVIEW- Introduction to NURECA- -Incorporated on 2nd November 2016 @Delhi. -B2C Home healthcare and wellness product company. -95% Revenue online. -1 manufacturing unit-@Chandigarh. -3 Brands. What does the company do- -company enables people with tools to effectively monitor chronic illness and …
NURECA IPO GMP Today – (LIVE DATA) Latest Grey …
WebNureca Limited IPO Review and Analysis in Hindi along with all the necessary details about this upcoming IPO. A fairly young company, Nureca is coming up wit... WebNureca Technologies Private Limited is a 2 years 8 months old, private Indian Company, registered at Mohali with a paid-up capital of Rs.30000000.0. Find details of its financials, directors, ... What is the Incorporation or founding … natural joint health for dogs
Founders - Administratie & fiscale knowhow
Web26 feb. 2024 · Nureca Ltd IPO – Promoters The Promoter of this company is: SAURABH GOYAL List of Related Parties (Key Managerial Personnel) Aryan Goyal, Chief Executive Officer Sakshi Mittal, Chief Financial Officer Gurvikram Singh, Company Secretary and Compliance Officer Nureca IPO Promoter Holding Pre Issue Share Holding – 46.67% … Web10 feb. 2024 · Nureca is a Company based in Mumbai which specializes in the business of home healthcare and wellness products that offers quality, durability, functionality, usability and innovative designs. They also have a range of products which allows the users to track their chronic ailment and other diseases in order to improve one’s lifestyle. WebNureca Limited is a healthcare and wellness products distributor. The company aims to offer the best quality, durable, and innovative tools to customers to monitor chronic diseases … marie osmond in the news